🔥🐔 BizChicken 🐔🔥
Companies Similar to Dynavax Technologies Corporation
Sign Up Today!
Sign up for BizChicken and discover more about the corporations around you.
Biogen Inc.
TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, FAMPYRA, SPINRAZA, FUMADERM, BENEPALI, ADUHELM, IMRALDI, FLIXABI, RITUXAN, RITUXAN HYCELA, GAZYVA, OCREVUS
Biogen Inc. focuses on discovering, developing, manufacturing, and delivering therapies for neurological and neurodegenerative diseases, including multiple sclerosis, spinal muscular atrophy, plaque psoriasis, Alzheimer's disease, and various cancers and autoimmune conditions.
About | About | Vision/Values | Leadership | Foundation | Contact | Careers | Careers | Careers | Careers | Careers | About | About | Careers | Careers | Careers | Careers | Benefits | Careers | Careers | Careers | Careers | About | About | About | About
Symbol: BIIB
Recent Price: $150.19
Industry: Drug Manufacturers - General
CEO: Mr. Christopher A. Viehbacher
Sector: Healthcare
Employees: 7570
Address: 225 Binney Street, Cambridge, MA 02142
Phone: 617 679 2000
Leadership
- Christopher A. Viehbacher, President and Chief Executive Officer
- Susan H. Alexander, Chief Legal Officer
- Ginger Gregory, Ph.D., Chief Human Resources Officer
- Jane Grogan, Ph.D., Head of Research
- Rachid Izzar, Head of Global Product Strategy & Commercialization
- Adam Keeney, Head of Corporate Development
- Michael McDonnell, Chief Financial Officer
- Nicole Murphy, Head of Pharmaceutical Operations and Technology
- Priya Singhal, M.D., M.P.H., Head of Development and Interim Chief Medical Officer
- Alisha Alaimo, President, Head of North America
- Stephen Amato, Head of Investor Relations
- Natacha Gassenbach, Head of Corporate Affairs, Chief Communications Officer
- Fraser Hall, President, Head of Intercontinental Region
- Wolfram Schmidt, President, Head of Europe
- Kendra Thomas, Head of Global Workforce Diversity, Equity & Inclusion (DE&I)
- Caroline Dorsa, Chair of the Board
- Maria C. Freire, Ph.D., Director
- William A. Hawkins, Director
- Susan Langer, Director
- Jesus B. Mantas, Director
- Lloyd B. Minor, M.D., Director
- Monish Patolawala, Director
- Eric K. Rowinsky, M.D., Director
- Stephen A. Sherwin, M.D., Director
Last updated: 2024-12-31
Dynavax Technologies Corporation
HEPLISAV-B
Dynavax Technologies Corporation is a biopharmaceutical company focusing on the development and commercialization of novel vaccines, including HEPLISAV-B, a hepatitis B vaccine. It collaborates with several international partners and is headquartered in Emeryville, California.
About | About | ESG | Contact | Contact | Careers | Careers | Benefits | About | About | Careers | Careers | Vision/Values
Symbol: DVAX
Recent Price: $12.83
Industry: Drug Manufacturers - Specialty & Generic
CEO: Mr. Ryan Spencer
Sector: Healthcare
Employees: 408
Address: 2100 Powell Street, EmeryVille, CA 94608
Phone: 510 848 5100
Last updated: 2024-12-31
Hepion Pharmaceuticals, Inc.
Rencofilstat
Hepion Pharmaceuticals, Inc. is a biopharmaceutical company focused on developing drug therapies for chronic liver diseases, particularly through the development of Rencofilstat, a cyclophilin inhibitor aimed at treating non-alcoholic steatohepatitis (NASH) and reducing liver fibrosis and tumors.
About | Leadership | About | About | About | News | Contact | Careers | About | About | About
Symbol: HEPA
Recent Price: $0.43
Industry: Biotechnology
CEO: Mr. John Patrick Brancaccio CPA
Sector: Healthcare
Employees: 22
Address: 399 Thornall Street, Edison, NJ 08837
Phone: 732 902 4000
Leadership
- John P. Brancaccio, Interim Chief Executive Officer, Interim Chief Financial Officer, and Chairman of the Board
Last updated: 2024-12-31
Halozyme Therapeutics, Inc.
ENHANZE drug delivery technology
Halozyme Therapeutics, Inc. is a biopharma technology platform company specializing in enabling subcutaneous delivery of biologics using its patented ENHANZE technology. The company operates in the United States and internationally, offering products such as Hylenex recombinant and developing treatments for various medical conditions including lymphomas and immunodeficiency disorders.
Symbol: HALO
Recent Price: $47.99
Industry: Biotechnology
CEO: Dr. Helen I. Torley M.B. Ch. B., M.R.C.P.
Sector: Healthcare
Employees: 373
Address: 11388 Sorrento Valley Road, San Diego, CA 92121
Phone: 858 794 8889
Last updated: 2024-12-31
ImmunityBio, Inc.
Therapies and Vaccines
Immunity Bio, Inc. is a clinical-stage biotechnology company developing therapies and vaccines to treat cancers and infectious diseases, with a focus on immunotherapy and cell therapy platforms. The company collaborates with several institutes and has multiple therapeutic agents in clinical trials.
Symbol: IBRX
Recent Price: $2.68
Industry: Biotechnology
CEO: Mr. Richard Gerald Adcock
Sector: Healthcare
Employees: 622
Address: 3530 John Hopkins Court, San Diego, CA 92121
Phone: 858 633 0300
Last updated: 2024-12-31
Novavax, Inc.
NVX-Co V2373
Novavax, Inc. is a biotechnology company focused on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases. Their vaccine candidates include NVX-Co V2373, Nano Flu, and Res Vax. The company operates collaboratively with Takeda Pharmaceutical Company Limited on COVID-19 vaccine development.
Contact | Careers | Careers | Careers | Careers | About | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | About | About | About | About | About | About
Symbol: NVAX
Recent Price: $7.93
Industry: Biotechnology
CEO: Mr. John Charles Jacobs M.B.A.
Sector: Healthcare
Employees: 1543
Address: 21 Firstfield Road, Gaithersburg, MD 20878
Phone: 240 268 2000
Last updated: 2024-12-31
Spyre Therapeutics, Inc.
antibody therapeutics
Spyre Therapeutics, Inc. is a biotechnology company focusing on antibody therapeutics for treating inflammatory bowel disease, using advanced engineering and precision medicine.
Symbol: SYRE
Recent Price: $22.54
Industry: Biotechnology
CEO: Dr. Cameron Turtle DPHIL, Ph.D.
Sector: Healthcare
Employees: 50
Address: 221 Crescent Street, Waltham, MA 02453
Phone: 617 651 5940
Last updated: 2024-12-31
Vaccinex, Inc.
pepinemab
Vaccinex, Inc., a clinical-stage biotechnology company, focuses on developing targeted biotherapeutics for cancer, neurodegenerative diseases, and autoimmune disorders. Its lead product candidate, pepinemab, is in clinical trials for multiple serious conditions.
Contact | Contact | Careers | About | Careers | About | About | About | About | About | News | Events | About | About | ESG | About | About | About | About | About
Symbol: VCNX
Recent Price: $1.11
Industry: Biotechnology
CEO: Dr. Maurice Zauderer Ph.D.
Sector: Healthcare
Employees: 37
Address: 1895 Mount Hope Avenue, Rochester, NY 14620
Phone: 585 271 2700
Last updated: 2024-12-31
Pfizer Inc.
biopharmaceutical products
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide, offering medicines and vaccines across various therapeutic areas.
About | About | About | About | About | About | About | About | About | About | DEI | ESG | About | Safety | About | ESG | About | About | About | About | About | About | About | About | About | About | History | About | About | About | About | About | About | News | About | Directors | Contact | Careers | Careers | Careers | Careers | Careers | Careers | DEI | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | About | About | About | About | About
Symbol: PFE
Recent Price: $26.42
Industry: Drug Manufacturers - General
CEO: Dr. Albert Bourla D.V.M., Ph.D.
Sector: Healthcare
Employees: 88000
Address: 235 East 42nd Street, New York, NY 10017
Phone: 212 733 2323
Last updated: 2024-12-31
Assembly Biosciences, Inc.
Vebicorvir
Assembly Biosciences, Inc. is a clinical-stage biotechnology company focused on discovering and developing therapeutic candidates for the treatment of hepatitis B virus (HBV) infection. Their lead product candidate, Vebicorvir, has completed Phase 2 clinical trials. The company is engaged in additional development and collaboration agreements to advance treatments for HBV.
Symbol: ASMB
Recent Price: $16.03
Industry: Biotechnology
CEO: Mr. Jason A. Okazaki
Sector: Healthcare
Employees: 65
Address: 331 Oyster Point Boulevard, South San Francisco, CA 94080
Phone: 833 509 4583
Last updated: 2024-12-31
BeiGene, Ltd.
BRUKINSA, Tislelizumab, REVLIMID, VIDAZA, XGEVA, BLINCYTO, KYPROLIS, SYLVANT, QARZIBA, Pamiparib, Pobevcy
Bei Gene, Ltd. is a biotechnology company focused on discovering, developing, manufacturing, and commercializing a wide range of medicines globally, specializing in oncology treatments and clinical stage drug candidates.
About | About | Vision/Values | About | About | Culture | DEI | Culture | Leadership | About | Contact | Careers | Careers | Careers | Careers | About | About | About | About | About | Jobs | About | About | About
Symbol: BGNE
Recent Price: $183.81
Industry: Biotechnology
CEO: Mr. John V. Oyler
Sector: Healthcare
Employees: 10000
Address: 55 Cambridge Parkway, Cambridge, MA 02142
Phone: 781-801-1800
Leadership
- John V. Oyler, Co-Founder, Chairman and CEO
- Xiaodong Wang, Ph.D., Co-Founder, Chairman of Scientific Advisory Board
- Olivier Brandicourt, M.D., Director
- Margaret Dugan, M.D., Director
- Donald W. Glazer, Director
- Michael Goller, Director
- Anthony Hooper, Director
- Ranjeev Krishana, Director
- Michael Nuoqing Yi, Director
- Alessandro Riva, M.D., Director
- Corsee Sanders, Ph.D., Director
- Shalini Sharp, Director
- Steven Young, Ph.D., Acting Head of Medicinal Chemistry
- Ron Levy, M.D., Scientific Advisory Board
- Neal Rosen, M.D., Ph.D., Scientific Advisory Board
- Charles Sawyers, M.D., Scientific Advisory Board
- David Schenkein, M.D., Scientific Advisory Board
- Melika Davis, SVP & Global Head, Clinical Operations
- Clare Fisher, SVP, Business Development, Licensing, and M&A (ex-China)
- Tony Guo, Ph.D., SVP, Global Statistics & Data Science
- Dany Habr, M.D., Head of Medical Affairs, North America & International Markets
- Graham Hardiman, Global Head of HR
- Shreya Devendra Jani, SVP, Corporate Affairs
- Jaspreet Jaggi, M.D., Ph.D., SVP and Head, Clinical Portfolio Strategy
- Yang Ji, Chief Compliance Officer
- Mark Lanasa, M.D., Ph.D., SVP, Chief Medical Officer, Solid Tumors
- Chan Lee, General Counsel
- Kyu-Sung Lee, Ph.D., SVP, Global Head of Technical Operations and Manufacturing
- Julie Lepin, Senior Vice President and Chief Regulatory Affairs Officer
- Kyoung Lim, VP of Supply Chain
- Han Ma, M.D., Ph.D., Chief Safety Officer and SVP, Global Patient Safety
- Mehrdad Mobasher, M.D., M.P.H., Chief Medical Officer, Hematology
- Richard O’Keeffe, Head of Global Quality
- Jurij Petrin, M.D., Head of New Market Development
- Yan Qi, Ph.D., SVP, Head of Public Affairs
- Hongyu Qian, SVP, Medical Affairs
- Jason Radford, SVP, Strategy & Corporate Development
- Anand Reddi, VP, Global Strategic Initiatives and Corporate Operations, Chief of Staff to the CEO
- Adam Roach, VP and Head of Asia Pacific
- Aaron Rosenberg, Chief Financial Officer
- Michael Schoen, Strategic Advisor and Special Assistant to the CEO
- Matt Shaulis, General Manager of North America
- Lai Wang, Ph.D., Global Head of R&D
- Zhiwei Wang, Ph.D., SVP, Research Head of Chemistry
- Beth Wensley, SVP, Head of Portfolio and Program Management
- Kimberly Wolf, SVP, Global Commercial Strategy & Operations
- Xiaobin Wu, Ph.D., President, Chief Operating Officer
- Eva Yin, Chief Commercial Officer, Greater China
Last updated: 2024-12-31
GeoVax Labs, Inc.
Modified Vaccinia Ankara Virus-Like Particle Vaccine Platform
Geo Vax Labs, Inc. develops human vaccines and immunotherapies against infectious diseases and cancers using its proprietary modified vaccinia ankara virus-like particle vaccine platform. The company focuses on preventive vaccines for diseases like COVID-19, HIV, Zika, malaria, and hemorrhagic fever viruses, as well as therapeutic vaccines for HIV and chronic Hepatitis B.
Symbol: GOVX
Recent Price: $2.44
Industry: Biotechnology
CEO: Mr. David Alan Dodd
Sector: Healthcare
Employees: 17
Address: 1900 Lake Park Drive, Smyrna, GA 30080
Phone: 678 384 7220
Last updated: 2024-12-31
HilleVax, Inc.
HIL-214
Hille Vax, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel vaccines, including HIL-214, for the prevention of norovirus infection.
Symbol: HLVX
Recent Price: $1.98
Industry: Biotechnology
CEO: Dr. Robert M. Hershberg M.D., Ph.D.
Sector: Healthcare
Employees: 90
Address: 75 State Street, Boston, MA 02109
Phone: 617 213 5054
Last updated: 2024-12-31
Vaxcyte, Inc.
VAX-24
Vaxcyte, Inc. is a clinical-stage biotechnology company developing novel protein vaccines for preventing or treating bacterial infectious diseases. Key products include the VAX-24 pneumococcal conjugate vaccine and other candidates targeting antibiotic resistance and periodontitis.
Symbol: PCVX
Recent Price: $81.99
Industry: Biotechnology
CEO: Mr. Grant E. Pickering M.B.A.
Sector: Healthcare
Employees: 254
Address: 825 Industrial Road, San Carlos, CA 94070
Phone: 650 837 0111
Last updated: 2024-12-31
Renovaro Biosciences Inc.
RENB-HV-01, RENB-HV-12, RENB-HB-01, RENB-DC-11, RENB-DC-12-XX, RENB-HV-21
Renovaro Biosciences Inc. is a pre-clinical stage biotechnology company focused on R&D of pharmaceutical and biological products for treating HIV, HBV, and cancer in the U.S. The company has a robust product pipeline and strategic partnerships, and was formerly known as Enochian Biosciences, Inc.
Symbol: RENB
Recent Price: $0.87
Industry: Biotechnology
CEO: Mr. David H. Weinstein
Sector: Healthcare
Employees: 25
Address: 2080 Century Park East, Los Angeles, CA 90067
Phone: 305 918 1980
Last updated: 2024-12-31
Vir Biotechnology, Inc.
Sotrovimab (VIR-7832), VIR-2218, VIR-3434, VIR-2482, VIR-1111
Vir Biotechnology, Inc. is a commercial-stage immunology company developing therapeutic products to treat and prevent serious infectious diseases, including COVID-19, hepatitis B, influenza A, and HIV.
Vision/Values | About | Leadership | About | Contact | Contact | Careers | Jobs | About | About
Symbol: VIR
Recent Price: $7.33
Industry: Biotechnology
CEO: Dr. Marianne De Backer M.B.A., M.Sc., Ph.D.
Sector: Healthcare
Employees: 587
Address: 499 Illinois Street, San Francisco, CA 94158
Phone: 415 906 4324
Leadership
- Marianne De Backer, M.Sc., Ph.D., MBA, Chief Executive Officer and Director
- Jeff Calcagno, M.D., Executive Vice President and Chief Business Officer
- Vanina de Verneuil, J.D., Executive Vice President, General Counsel and Corporate Secretary
- Mika Kakefuda Derynck, M.D., Executive Vice President, Therapeutic Area Head Oncology
- Mark Eisner, M.D., M.P.H., Executive Vice President and Chief Medical Officer
- Jenny Gumm, Ed.D., MBA, Executive Vice President, Chief Human Resources Officer
- Aine Hanly, Ph.D., Executive Vice President and Chief Technology Officer
- Jason O’Byrne, MBA, Executive Vice President and Chief Financial Officer
- Jennifer Eileen Towne, Ph.D., Executive Vice President and Chief Scientific Officer
- Arran Attridge, Senior Vice President Corporate Communications
- Antonio Lanzavecchia, M.D., Senior Vice President and Senior Research Fellow
- Amalio Telenti, M.D, Ph.D., Executive Vice President and Senior Research Fellow
Last updated: 2024-12-31
Vaxxinity, Inc.
UB-311, UB-312, UB-313, UB-612
Vaxxinity, Inc. is a biotechnology company focused on developing product candidates for neurology and coronavirus-related treatments, including Alzheimer's, Parkinson's disease, migraines, and SARS-CoV-2.
Symbol: VAXX
Recent Price: $0.00
Industry: Biotechnology
CEO: Ms. Mei Mei Hu J.D.
Sector: Healthcare
Employees: 57
Address: 1717 Main Street, Dallas, TX 75201
Phone: 254 244 5739
Last updated: 2024-11-08
Vaxart, Inc.
Oral Recombinant Protein Vaccines
Vaxart, Inc. is a clinical-stage biotechnology company focused on developing oral recombinant protein vaccines using a proprietary oral vaccine platform. Their product pipeline includes vaccines for norovirus, seasonal influenza, respiratory syncytial virus, and coronavirus, along with therapeutic vaccines for cervical cancer and dysplasia.
Symbol: VXRT
Recent Price: $0.69
Industry: Biotechnology
CEO: Mr. Steven Lo
Sector: Healthcare
Employees: 109
Address: 170 Harbor Way, South San Francisco, CA 94080
Phone: 650 550 3500
Last updated: 2024-12-31
Arbutus Biopharma Corporation
AB-729, AB-836, AB-161, AB-101
Arbutus Biopharma Corporation is a biopharmaceutical company that develops novel therapeutics for chronic Hepatitis B virus (HBV) infection, SARS-CoV-2, and other coronaviruses. The company's HBV product pipeline includes RNA interference products and oral capsid inhibitors, and it is involved in strategic alliances for research and development.
About | Leadership | Directors | Contact | Contact | Culture | Jobs | Culture | About | About
Symbol: ABUS
Recent Price: $3.20
Industry: Biotechnology
CEO: Mr. Michael J. McElhaugh
Sector: Healthcare
Employees: 73
Address: 701 Veterans Circle, Warminster, PA 18974
Phone: 267 469 0914
Leadership
- Michael J. McElhaugh, Interim President and Chief Executive Officer and Director
- Michael J. Sofia PhD, Chief Scientific Officer
- Karen Sims, MD, PhD, Chief Medical Officer
- David C. Hastings, Chief Financial Officer
- Christopher Naftzger, General Counsel and Chief Compliance Officer
- Lisa Caperelli, Vice President, Investor Relations
- Shannon Briscoe, SPHR, SHRM-SCP, Vice President, Human Resources
- Frank Torti, MD, Chairman
- Daniel Burgess, Independent Director
- Richard C. Henriques, Independent Director
- Keith Manchester, MD, Independent Director
- James Meyers, Independent Director
- Melissa V. Rewolinski, PhD, Independent Director
Last updated: 2024-12-31
Enanta Pharmaceuticals, Inc.
N/A
Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases, with targets including respiratory syncytial virus, SARS-Co V-2, human metapneumovirus, and hepatitis B virus.
About | Leadership | Directors | Contact | Careers | Careers | Culture | About | About | About
Symbol: ENTA
Recent Price: $5.85
Industry: Biotechnology
CEO: Dr. Jay R. Luly Ph.D.
Sector: Healthcare
Employees: 145
Address: 500 Arsenal Street, Watertown, MA 02472
Phone: 617 607 0800
Leadership
- Jay R. Luly, Ph.D., President, Chief Executive Officer and Director
- Tara L. Kieffer, Ph.D., Chief Product Strategy Officer
- Matthew P. Kowalsky, J.D., Chief Legal Officer
- Brendan Luu, Chief Business Officer
- Paul J. Mellett, Chief Financial and Administrative Officer
- Yat Sun Or, Ph.D., Chief Scientific Officer
- Scott T. Rottinghaus, M.D., Chief Medical Officer
- Bruce L.A. Carter, Ph.D., Chairman of the Board
- Mark G. Foletta, Board Member
- Yujiro S. Hata, Board Member
- Kristine Peterson, Board Member
- Lesley Russell, MBChB, MRCPb, Board Member
- Terry Vance, Board Member
Last updated: 2024-12-31